126 related articles for article (PubMed ID: 22125088)
21. Agreement between hospital discharge diagnosis codes and medical records to identify metastatic colorectal cancer and associated comorbidities in elderly patients.
Gouverneur A; Dolatkhani D; Rouyer M; Grelaud A; Francis F; Gilleron V; Fourrier-Réglat A; Noize P
Rev Epidemiol Sante Publique; 2017 Aug; 65(4):321-325. PubMed ID: 28576381
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA.
Franchi M; Barni S; Tagliabue G; Ricci P; Mazzucco W; Tumino R; Caputo A; Corrao G;
Oncologist; 2019 Mar; 24(3):358-365. PubMed ID: 30097524
[TBL] [Abstract][Full Text] [Related]
23. DNA oxidation in patients with metastastic colorectal cancer: clinical significance of 8-hydroxy-deoxyguanosine as an independent prognostic factor.
Burlaka AA; Vovk AV; Burlaka AP; Kolesnik OO
Exp Oncol; 2019 Mar; 41(1):26-31. PubMed ID: 30932412
[TBL] [Abstract][Full Text] [Related]
24. Primary tumor resection in patients presenting with metastatic colorectal cancer: analysis of a provincial population-based cohort.
Chan TW; Brown C; Ho CC; Gill S
Am J Clin Oncol; 2010 Feb; 33(1):52-5. PubMed ID: 19704367
[TBL] [Abstract][Full Text] [Related]
25. Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study.
Keikes L; Koopman M; Stuiver MM; Lemmens VEPP; van Oijen MGH; Punt CJA
Acta Oncol; 2020 Apr; 59(4):395-403. PubMed ID: 32048563
[No Abstract] [Full Text] [Related]
26. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
Grande R; Natoli C; Ciancola F; Gemma D; Pellegrino A; Pavese I; Garufi C; Di Lauro L; Corsi D; Signorelli D; Sperduti I; Cortese G; Risi E; Morano F; Sergi D; Signorelli C; Ruggeri EM; Zampa G; Russano M; Gamucci T
PLoS One; 2016; 11(7):e0157751. PubMed ID: 27442239
[TBL] [Abstract][Full Text] [Related]
28. recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival.
Hill CR; Chagpar RB; Callender GG; Brown RE; Gilbert JE; Martin RC; McMasters KM; Scoggins CR
Ann Surg Oncol; 2012 Jan; 19(1):139-44. PubMed ID: 21751045
[TBL] [Abstract][Full Text] [Related]
29. RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014.
Lièvre A; Merlin JL; Sabourin JC; Artru P; Tong S; Libert L; Audhuy F; Gicquel C; Moureau-Zabotto L; Ossendza RA; Laurent-Puig P; Ducreux M
Dig Liver Dis; 2018 May; 50(5):507-512. PubMed ID: 29396127
[TBL] [Abstract][Full Text] [Related]
30. Observational Cohort Study of Patients With Metastatic Colorectal Cancer Initiating Chemotherapy in Combination With Bevacizumab (CONCERT).
Bennouna J; Phelip JM; André T; Asselain B; Sébastien Koné ; Ducreux M
Clin Colorectal Cancer; 2017 Jun; 16(2):129-140.e4. PubMed ID: 28277294
[TBL] [Abstract][Full Text] [Related]
31. Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis.
Cao D; Zheng Y; Xu H; Ge W; Xu X
Sci Rep; 2019 Dec; 9(1):20326. PubMed ID: 31889159
[TBL] [Abstract][Full Text] [Related]
32. Left Versus Right: Does Location Matter for Refractory Metastatic Colorectal Cancer Patients in Phase 1 Clinical Trials?
Arora SP; Ketchum NS; Michalek J; Gelfond J; Mahalingam D
J Gastrointest Cancer; 2018 Sep; 49(3):283-287. PubMed ID: 28432610
[TBL] [Abstract][Full Text] [Related]
33. Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.
Turner N; Tran B; Tran PV; Sinnathamby M; Wong HL; Jones I; Croxford M; Desai J; Tie J; Field KM; Kosmider S; Bae S; Gibbs P
Clin Colorectal Cancer; 2015 Sep; 14(3):185-91. PubMed ID: 25882598
[TBL] [Abstract][Full Text] [Related]
34. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
35. Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme.
Iveson T; Carter AM; Shiu KK; Spooner C; Stevens D; Mullamitha S
BMC Cancer; 2020 Feb; 20(1):91. PubMed ID: 32013902
[TBL] [Abstract][Full Text] [Related]
36. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
Tomita Y; Karapetis CS; Ullah S; Townsend AR; Roder D; Beeke C; Roy AC; Padbury R; Price TJ
Acta Oncol; 2016; 55(4):480-5. PubMed ID: 26878155
[TBL] [Abstract][Full Text] [Related]
37. Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.
Song X; Zhao Z; Barber B; Gregory C; Wang PF; Long SR
Curr Med Res Opin; 2011 Jan; 27(1):123-30. PubMed ID: 21128878
[TBL] [Abstract][Full Text] [Related]
38. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
[TBL] [Abstract][Full Text] [Related]
39. [Metastatic colorectal cancer--analysis of treatment modalities and survival now and then].
Michl M; Holtzem B; Koch J; Moosmann N; Holch J; Hiddemann W; Heinemann V
Dtsch Med Wochenschr; 2014 Oct; 139(41):2068-72. PubMed ID: 25268205
[TBL] [Abstract][Full Text] [Related]
40. Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective.
Marchetti P; Maass N; Gligorov J; Berger K; MacDougall F; Montonen J; Lewis J
Breast; 2017 Apr; 32():247-255. PubMed ID: 28011074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
